Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy
Authors
Keywords
-
Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 60, Issue 50, Pages 26320-26326
Publisher
Wiley
Online
2021-10-21
DOI
10.1002/anie.202108342
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Capturing Cytokines with Advanced Materials: A Potential Strategy to Tackle COVID‐19 Cytokine Storm
- (2021) Qian‐Fang Meng et al. ADVANCED MATERIALS
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
- (2020) Yuqiong Xia et al. ADVANCED MATERIALS
- Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
- (2020) Lang Rao et al. ADVANCED MATERIALS
- Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines
- (2020) Lang Rao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
- (2020) Lang Rao et al. Nature Communications
- A materials-science perspective on tackling COVID-19
- (2020) Zhongmin Tang et al. Nature Reviews Materials
- Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells
- (2020) Ling Li et al. Nature Biomedical Engineering
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Cancer nanomedicine for combination cancer immunotherapy
- (2019) Jutaek Nam et al. Nature Reviews Materials
- Bioresponsive Protein Complex of aPD1 and aCD47 Antibodies for Enhanced Immunotherapy
- (2019) Qian Chen et al. NANO LETTERS
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells
- (2019) Wen-Long Liu et al. Nature Communications
- Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
- (2019) Xiao Han et al. Science Advances
- Cell Membrane Coating Nanotechnology
- (2018) Ronnie H. Fang et al. ADVANCED MATERIALS
- PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy
- (2018) Xudong Zhang et al. ADVANCED MATERIALS
- Myeloid-Derived Suppressor Cell Membrane-Coated Magnetic Nanoparticles for Cancer Theranostics by Inducing Macrophage Polarization and Synergizing Immunogenic Cell Death
- (2018) Guang-Tao Yu et al. ADVANCED FUNCTIONAL MATERIALS
- Engineering PD-1-Presenting Platelets for Cancer Immunotherapy
- (2018) Xudong Zhang et al. NANO LETTERS
- Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion
- (2018) Xiaojuan Liu et al. Cell Reports
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
- (2017) Sushrut Kamerkar et al. NATURE
- Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges
- (2017) Nicholas L. Syn et al. TRENDS IN BIOTECHNOLOGY
- Rethinking cancer nanotheranostics
- (2017) Hongmin Chen et al. Nature Reviews Materials
- In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
- (2017) Chao Wang et al. Nature Biomedical Engineering
- Cancer Cell Membrane-Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging
- (2016) Lang Rao et al. ADVANCED MATERIALS
- Biomimetic proteolipid vesicles for targeting inflamed tissues
- (2016) R. Molinaro et al. NATURE MATERIALS
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Nanoparticle biointerfacing by platelet membrane cloaking
- (2015) Che-Ming J. Hu et al. NATURE
- CD47 blockade as another immune checkpoint therapy for cancer
- (2015) Robert H Vonderheide NATURE MEDICINE
- Virus-mimetic nanovesicles as a versatile antigen-delivery system
- (2015) Pengfei Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma
- (2015) Guang-Tao Yu et al. Oncotarget
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant Tumors
- (2013) Su Chul Jang et al. ACS Nano
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Extracellular vesicles: biology and emerging therapeutic opportunities
- (2013) Samir EL Andaloussi et al. NATURE REVIEWS DRUG DISCOVERY
- Engineered SIRP Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
- (2013) K. Weiskopf et al. SCIENCE
- Fusion protein linkers: Property, design and functionality
- (2012) Xiaoying Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
- (2011) C.-M. J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
- (2009) Siddhartha Jaiswal et al. CELL
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started